Normal hearing and synaptic transmission at afferent auditory inner hair cell (IHC) synapses require otoferlin. Deafness DFNB9, caused by mutations in the OTOF gene encoding otoferlin, might be treated by transferring wild-type otoferlin cDNA into IHCs, which is difficult due to the large size of this transgene. In this study, we generated two adeno-associated viruses (AAVs), each containing half of the otoferlin cDNA Co-injecting these dual-AAV2/6 half-vectors into the cochleae of 6- to 7-day-old otoferlin knock-out (Otof -/-) mice led to the expression of full-length otoferlin in up to 50% of IHCs. In the cochlea, otoferlin was selectively expressed in auditory hair cells. Dual-AAV transduction of Otof -/- IHCs fully restored fast exocyto...
Abstract OTOF mutations are the principal causes of auditory neuropathy. There are reports on Otof‐r...
Mammalian inner ear harbors diverse cell types that are essential for hearing and balance. Adenoviru...
Adeno-associated virus (AAV) is the preferred vector for gene therapy of hereditary deafness, and di...
Otoferlin is a large multi-C2 domain protein indispensable for hearing and synaptic transmission in ...
International audienceAutosomal recessive genetic forms (DFNB) account for most cases of profound co...
Gene therapy for genetic hearing loss is a nascent field with just a handful of studies published to...
Adeno-associated virus (AAV) is a safe and effective vector for gene therapy for retinal disorders. ...
Gene delivery is a key component for the treatment of genetic hearing loss. To date, a myriad of ade...
Hereditary hearing loss often results from mutation of genes expressed by cochlear hair cells. Gene ...
Efforts to develop gene therapies for hearing loss have been hampered by the lack of safe, efficient...
SummaryMice lacking the vesicular glutamate transporter-3 (VGLUT3) are congenitally deaf due to loss...
peer reviewedMutations and deletions in the gene or upstream of the gene encoding the POU3F4 transc...
We have previously shown that in vitro transduction with bovine adeno-associated viral (BAAV) vector...
Viral delivery of exogenous coding sequences into the inner ear has the potential for therapeutic be...
Efforts to develop gene therapies for hearing loss have been hampered by the lack of safe, efficient...
Abstract OTOF mutations are the principal causes of auditory neuropathy. There are reports on Otof‐r...
Mammalian inner ear harbors diverse cell types that are essential for hearing and balance. Adenoviru...
Adeno-associated virus (AAV) is the preferred vector for gene therapy of hereditary deafness, and di...
Otoferlin is a large multi-C2 domain protein indispensable for hearing and synaptic transmission in ...
International audienceAutosomal recessive genetic forms (DFNB) account for most cases of profound co...
Gene therapy for genetic hearing loss is a nascent field with just a handful of studies published to...
Adeno-associated virus (AAV) is a safe and effective vector for gene therapy for retinal disorders. ...
Gene delivery is a key component for the treatment of genetic hearing loss. To date, a myriad of ade...
Hereditary hearing loss often results from mutation of genes expressed by cochlear hair cells. Gene ...
Efforts to develop gene therapies for hearing loss have been hampered by the lack of safe, efficient...
SummaryMice lacking the vesicular glutamate transporter-3 (VGLUT3) are congenitally deaf due to loss...
peer reviewedMutations and deletions in the gene or upstream of the gene encoding the POU3F4 transc...
We have previously shown that in vitro transduction with bovine adeno-associated viral (BAAV) vector...
Viral delivery of exogenous coding sequences into the inner ear has the potential for therapeutic be...
Efforts to develop gene therapies for hearing loss have been hampered by the lack of safe, efficient...
Abstract OTOF mutations are the principal causes of auditory neuropathy. There are reports on Otof‐r...
Mammalian inner ear harbors diverse cell types that are essential for hearing and balance. Adenoviru...
Adeno-associated virus (AAV) is the preferred vector for gene therapy of hereditary deafness, and di...